Author： Capetti Amedeo Rizzardini Giuliano
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.9, 2014-06, pp. : 1289-1298
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 2, 2009-04 ,pp. :
Access to resources
Recommend
By Tross Susan Campbell Aimee N. C. Calsyn Donald A. Metsch Lisa R. Sorensen James L. Shoptaw Steven Haynes Louise Woody George E. Malow Robert M. Brown Lawrence S. Feaster Daniel J. Booth Robert E. Mandler Raul N. Masson Carmen Holmes Beverly W. Colfax Grant Brooks Audrey J. Hien Denise A. Schackman Bruce R. Korthuis P. Todd Miele Gloria M.
The American Journal of Drug and Alcohol Abuse, Vol. 37, Iss. 5, 2011-09 ,pp. :
Raltegravir sets new BENCHMRK in treatment-resistant HIV
Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. :
Kidney disease a barrier to HIV treatment?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 543, 2007-01 ,pp. :